The Asia scoliosis management market is witnessing increasing attention as the prevalence of spinal deformities continues to create demand for effective diagnosis, treatment, and management solutions. According to Fortune Business Insights, the Asia scoliosis management market size was valued at USD 644.7 million in 2019. The market experienced a significant impact from the COVID-19 pandemic, resulting in a negative demand shock across regions. The market declined by 15.1% in 2020 and was valued at USD 547.3 million. It is projected to grow from USD 547.3 million in 2020 to USD 826.8 million by 2027, registering a CAGR of 6.1% during the 2020-2027 forecast period.
Scoliosis is characterized by an abnormal sideways curvature of the spine, which may create a C-shaped or S-shaped curve. The condition is commonly observed during adolescence or early youth. The increasing prevalence of juvenile and adolescent idiopathic scoliosis across Asia has become an important healthcare concern. Growing awareness, screening initiatives, technological advancements, and increasing adoption of advanced spinal procedures are supporting the development of the Asia scoliosis management market.
Growing Focus on Early Diagnosis and Screening
Early identification of scoliosis is becoming increasingly important across Asian countries. Government initiatives, healthcare programs, and screening activities are encouraging the identification of spinal deformities among children at an earlier stage. The Association of Spinal Surgeons of India launched a screening program across multiple cities to identify spinal deformities among school children, with the program aiming to reach around 1.5 lakh students over two years.
The growing focus on early diagnosis is expected to create opportunities for scoliosis management products. Increasing awareness of spinal health among children and families is also contributing to greater attention toward diagnosis and appropriate treatment.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 & 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀:
The rising incidence of scoliosis represents a major factor supporting market growth. According to Fortune Business Insights, most adolescents develop scoliosis between the ages of 11 and 18 years, accounting for approximately 80% of idiopathic scoliosis cases in children. A screening conducted by Peking Union Medical College Hospital in Beijing in 2016 among 21,759 children aged 8 to 14 years reported a prevalence rate of around 2.0%, with 80.5% of diagnosed patients having idiopathic scoliosis.
The shift toward minimally invasive spine surgeries is another factor supporting market development. Minimally invasive procedures can enable faster recovery compared with open spine procedures. Advances in navigation and imaging technologies, biologics, customizable implants, operative techniques, and evidence supporting the efficacy and feasibility of these procedures are contributing to increased interest in minimally invasive approaches.
However, product recalls and risks associated with spinal procedures may restrain market expansion. In March 2020, NuVasive issued an urgent field safety notice concerning separation of a component in certain MAGEC system model X rods. Post-procedural risks associated with spinal fusion surgeries, including pain, neurological damage, infection, inflammatory processes, curvature progression, and loss of normal spinal function, may also affect adoption.
Technological Advancements Create New Market Opportunities
Technological development is emerging as an important trend in scoliosis management. The adoption of 3D-printed computer-aided design models of the spine, finite element modeling, and design optimization techniques is supporting the development of new treatment tools and technologies.
In August 2019, Zimmer Biomet announced the approval of a spinal tether device intended for children and adolescents with idiopathic scoliosis who had not responded to conservative treatment options such as external bracing. The Tether – Vertebral Body Tethering System was designed for growing children and adolescents whose spinal curves were approaching or had reached a range where surgical treatment could be considered.
Artificial intelligence is also being incorporated into scoliosis diagnosis and screening. In Japan, an AI-embedded moiré imaging system is used in schools as a scoliosis screening tool. These developments demonstrate the growing role of technology in improving scoliosis screening and management across Asia.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:
The market is consolidated, with several prominent companies holding significant market positions. Medtronic held a prominent position in the market, supported by demand for its Mazor X Stealth Edition system. In December 2019, Medtronic announced the launch of the Mazor X Stealth Edition in India, providing an integrated solution for surgical planning, workflow, execution, and confirmation of spine surgeries.
Key companies profiled in the market include Medtronic, DePuy Synthes Companies, Zimmer Biomet, Orthofix Holdings, Aspen Medical Products, NuVasive, DJO Global, and OTTOBOCK, along with other prominent players.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀:
By Product (Orthosis System (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Lumbosacral Orthosis (LSO), Thoracolumbosacral Orthosis (TLSO))
By Disease Type (Adolescent Idiopathic Scoliosis, Degenerative Scoliosis)
By Age Group (Pediatrics, Adolescent, and Adults)
By End User (Hospital & ASCs, Clinics)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/asia-scoliosis-management-market-104534
𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:
China is expected to maintain a leading position in the Asia scoliosis management market. The market size in China reached USD 203.9 million in 2019. Increasing clinical trials for novel treatment solutions and investments by major companies in the Chinese spinal market are supporting the country's market footprint.
India is anticipated to witness considerable growth, supported by increasing public-private partnerships for scoliosis screening among children. Japan is also expected to benefit from the increasing prevalence of scoliosis, while government initiatives to raise awareness regarding the effects of prolonged scoliosis are supporting market development in Singapore. South Korea is projected to witness lucrative growth during the forecast period.
𝗙𝘂𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗰𝗼𝗽𝗲:
The future of the Asia scoliosis management market is expected to be shaped by increasing scoliosis prevalence, early diagnosis initiatives, minimally invasive procedures, and technological advancements. Continued development of spinal technologies, customized treatment solutions, screening programs, and innovative medical devices is expected to support market opportunities across Asia.
Uncover Japan’s Market Trends - Explore the Latest -Asia Scoliosis Management Market- Insights